Share
The pharma industry briefing
The latest news, approvals and clinical trials you need to know about this month
Data:
News
in Numbers
100
More than 100 children died in an outbreak of suspected encephalitis in India's Bihar state, according to officials
$11.4bn
Pfizer has a made a $48 per share play for Array Biopharma, which values the cancer specialist at $11.4 billion
$225 million
The potential price tag of Novartis’ new gene therapy drug, Zolgensma
Eight
Two pharmaceutical manufacturing facilities (one in India and one in China) have suffered explosions in just eight weeks, resulting in multiple fatalities
107
The number of generic drugs that Teva Pharmaceutical’s former senior vice president Maureen Cavanaugh has been accused of colluding to raise prices on
Data:
News
in Numbers
100
More than 100 children died in an outbreak of suspected encephalitis in India's Bihar state, according to officials
$11.4bn
Pfizer has a made a $48 per share play for Array Biopharma, which values the cancer specialist at $11.4 billion
Eight
Explosions at two pharmaceutical manufacturing facilities (one in China and one in India) have resulted in fatalities in just eight weeks
107
The number of generic drugs that Teva Pharmaceutical’s former senior vice president Maureen Cavanaugh has been accused of colluding to raise prices on
$225 million
The amount that Insys Therapeutics has agreed to pay to end to end criminal and civil investigations
DHL invests $150M to expand pharma, medical supply chain
DHL Supply Chain plans to invest $150 million to expand its distribution network of medical devices and pharmaceutical supplies.
Source: Supply Chain Dive
Survey shows crisis of confidence in vaccines in parts of Europe
A global survey of attitudes towards science has revealed the scale of the crisis of confidence in vaccines in Europe, showing that only 59% of people in western Europe and 50% in the east think vaccines are safe, compared with 79% worldwide.
Source: Guardian
Push to develop world’s first vaccine against the deadly Strep A bacteria
The British biomedical research foundation, the Wellcome Trust, has granted $2.25m to IVI & MCRI to coordinate efforts to develop world’s first vaccine against Strep A bacteria.
Source: Health Europa
Celgene dips out of deals ahead of mega-merger
Celgene has agreed to pay $150m to exit a two-year-old deal with BeiGene focused on developing and commercializing one of the Chinese biotech's immuno-oncology drugs.
Source: Bio Pharma Dive
AstraZeneca plans $630m Korea investment amid favourable policies
AstraZeneca is set to spend $630m on R&D in South Korea over the next five years. The commitment is part of a wider agreement between organizations in Korea and Sweden.
Source: Fierce Biotech
Approvals
NAYZILAM® (midazolam)
The US FDA has approved a New Drug Application for the UCB’s newest anti-epileptic drug (AED) NAYZILAM® (midazolam) nasal spray CIV.
Source: UCB
Zolgensma
The US FDA has approved Novartis AG’s Zolgensma, a gene therapy targeting children under two years old who have a severe illness called spinal muscular atrophy.
Source: FDA
Polivy (polatuzumab vedotin-piiq)
The US FDA has approved an antibody-drug conjugate to treat people with diffuse large B-cell lymphoma
Source: Cancer.org
Rozlytrek
Roche's personalised cancer drug Rozlytrek has been approved by regulators in Japan.
Source: Reuters
Go to top
Go to top
Share this article
